Jyong Biotech (NASDAQ:MENS) Shares Gap Down - Time to Sell?

Key Points

• Jyong Biotech shares opened at $58.51 after closing at $59.74, reflecting a gap down prior to trading on Monday.
• Analysts upgraded Jyong Biotech to a "hold" rating in a research note released on June 30th.
• Jyong Biotech's shares have decreased by 9.6%, with a fifty-day simple moving average of $42.84.

Shares of Jyong Biotech Ltd. (NASDAQ:MENS - Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $59.74, but opened at $58.51. Jyong Biotech shares last traded at $58.50, with a volume of 2,884 shares traded.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded shares of Jyong Biotech to a "hold" rating in a research note on Monday, June 30th.

Jyong Biotech Trading Down 9.6%

The business's fifty day simple moving average is $42.84.

Jyong Biotech Company Profile

OUR MISSION We endeavor to develop and supply first-class innovative drugs to meet our customers' health needs. We seek to be a valuable business organization that is held in high esteem by the public. We are a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.